Infection Surveillance Services Market to Reach $1.72 Billion by 2030, Driven by Rising Healthcare-Associated Infections

Plasma Therapy Market

Infection Surveillance Services Market Summary

According to a new report published by Allied Market Research, the global infection surveillance services market was valued at $407.06 million in 2020 and is projected to reach $1.72 billion by 2030, registering a robust CAGR of 14.5% from 2021 to 2030.

Infection surveillance services play a critical role in monitoring, identifying, and preventing healthcare-associated infections (HAIs). These services help healthcare facilities evaluate infection control programs, improve patient safety, and enhance overall healthcare quality through data-driven insights.

Market Drivers, Restraints, and Opportunities

The growth of the infection surveillance services market is primarily driven by the increasing prevalence of healthcare-associated infections, rising number of surgical procedures, and growing geriatric population vulnerable to infections. Additionally, increased government and private funding for infection prevention programs and the growing adoption of surveillance software among healthcare professionals are fueling market expansion.

Technological advancements, including real-time data analytics and digital health solutions, further accelerate market growth. However, the high cost associated with infection surveillance software is expected to restrain market expansion to some extent. Despite this, emerging economies and improvements in healthcare infrastructure present lucrative opportunities for industry players.

Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/13474

Segment Insights

Based on infection type, the surgical site infections segment dominated the market in 2020, owing to the increasing number of surgical procedures globally and the associated risk of infections. Meanwhile, the hospital-acquired pneumonia segment is expected to witness the fastest growth during the forecast period.

By offering, the software segment accounted for the largest market share, driven by the rising need for automated infection monitoring and reporting systems.

In terms of end users, hospitals and clinics held the dominant share, attributed to the high prevalence of HAIs and growing demand for electronic medical records and advanced infection control systems.

Regional Outlook

Regionally, North America dominated the infection surveillance services market in 2020, supported by advanced healthcare infrastructure, high adoption of digital surveillance technologies, and strong government initiatives to reduce HAIs.

However, the Asia-Pacific region is projected to register the highest CAGR of 16.6%, driven by increasing healthcare investments, rising awareness of infection control, and a growing patient population.

Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/13474

Competitive Landscape

Key players operating in the global infection surveillance services market include Alpha Source Inc., Baxter International Inc., Becton, Dickinson and Company, BioVigil, Gojo Industries Inc., International Business Machines Corporation, Premier Inc., RLDatix, S. C. Johnson & Son, Inc., and Wolters Kluwer.

These companies are focusing on strategic collaborations, product innovations, and technological advancements to strengthen their market presence and expand their global footprint.

Key Takeaways

  • Market projected to reach $1.72 billion by 2030
  • CAGR of 14.5% from 2021 to 2030
  • Growth driven by rising HAIs and adoption of surveillance software
  • Hospitals & clinics remain the largest end-user segment
  • Asia-Pacific expected to witness fastest growth

Other Trending Reports in Life Science Domain

How Big Is the Pharmaceutical Primary Packaging Label Market by 2032? Size, Share & CAGR Analysis

Urinary Incontinence Devices Market to Reach $6.18 Billion by 2030, Driven by Rising Geriatric Population and Technological Advancements

Dental Liners and Bases Market to Reach $1.99 Billion by 2030, Driven by Rising Dental Caries and Growing Demand for Restorative Procedures

Urinary Incontinence Market to Receive Overwhelming Hike In Revenue Will Boost Industry Growth by 2030

Hepatitis Therapeutics Market Size: $19.17 Billion by 2030 | 3.1% CAGR Growth

Downstream Processing Market to Reach $92.0 Billion by 2030, Driven by Rising Biopharmaceutical Demand

About Us: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. 

Allied Market Research

Allied Market Research

Allied Market Research (AMR) is approved by the Newstrail editorial board to share timely, data-driven insights. As a trusted leader in market research and analysis across multiple industries, AMR delivers in-depth reports and expert commentary to help businesses stay ahead of emerging trends.